Development and evaluation of a radiobromine-labeled sigma ligand for tumor imaging

Nuclear Medicine and Biology

Volumn 40, Issue 4, 2013, Pages 445-450

  Ogawa, Kazuma ^a   Kanbara, Hiroya ^a   Kiyono, Yasushi ^b   Kitamura, Yoji ^a   Kiwada, Tatsuto ^a   Kozaka, Takashi ^a   Kitamura, Masanori ^a   Mori, Tetsuya ^b   Shiba, Kazuhiro ^a   Odani, Akira ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

Radiobromine; Sigma receptor; Tumor

Indexed keywords

2 [4 [4 BROMOPHENYL]PIPERIDINO]CYCLOHEXANOL; 2 [4 [4 BROMOPHENYL]PIPERIDINO]CYCLOHEXANOL BR 77; 2 [4 [4 IODOPHENYL]PIPERIDINO]CYCLOHEXANOL; 2 [4 [4 IODOPHENYL]PIPERIDINO]CYCLOHEXANOL I 125; BROMINE 76; BROMINE 77; CUTAMESINE; CYCLOHEXANOL DERIVATIVE; DIAGNOSTIC AGENT; HALOPERIDOL; IODINE 125; RADIOBROMINE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG; VESAMICOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG ACCUMULATION; DRUG DEVELOPMENT; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG PURIFICATION; DRUG PURITY; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LIPOPHILICITY; LIVER; MALE; NONHUMAN; PARTITION COEFFICIENT; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR BINDING; TUMOR DIAGNOSIS;

ANIMALS; BINDING, COMPETITIVE; BIOLOGICAL TRANSPORT; BROMINE RADIOISOTOPES; CELL LINE, TUMOR; CYCLOHEXANOLS; DRUG DESIGN; HUMANS; ISOTOPE LABELING; LIGANDS; MICE; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RATS; RECEPTORS, SIGMA;

EID: 84876730003     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.02.008     Document Type: Article

References (28)

1. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976, 197:517-532.
2. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., et al. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 1992, 13:85-86.
3. Su T.P. Delineating biochemical and functional properties of sigma receptors: emerging concepts. Crit Rev Neurobiol 1993, 7:187-203.
4. Vilner B.J., John C.S., Bowen W.D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 1995, 55:408-413.
5. Bem W.T., Thomas G.E., Mamone J.Y., Homan S.M., Levy B.K., Johnson F.E., et al. Overexpression of sigma receptors in nonneural human tumors. Cancer Res 1991, 51:6558-6562.
6. Aydar E., Palmer C.P., Djamgoz M.B. Sigma receptors and cancer: possible involvement of ion channels. Cancer Res 2004, 64:5029-5035.
7. Aydar E., Onganer P., Perrett R., Djamgoz M.B., Palmer C.P. The expression and functional characterization of sigma 1 receptors in breast cancer cell lines. Cancer Lett 2006, 242:245-257.
8. Mach R.H., Smith C.R., al-Nabulsi I., Whirrett B.R., Childers S.R., Wheeler K.T. Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res 1997, 57:156-161.
9. Wheeler K.T., Wang L.M., Wallen C.A., Childers S.R., Cline J.M., Keng P.C., et al. Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer 2000, 82:1223-1232.
10. Hirata M., Mori T., Umeda T., Abe T., Yamamoto T., Ohmomo Y. Evaluation of radioiodinated 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(2-iodophenylpropyl)piperazine as a tumor diagnostic agent with functional sigma receptor imaging by single photon emission computed tomography. Biol Pharm Bull 2008, 31:879-883.
11. Megalizzi V., Mathieu V., Mijatovic T., Gailly P., Debeir O., De Neve N., et al. 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia 2007, 9:358-369.
12. Spruce B.A., Campbell L.A., McTavish N., Cooper M.A., Appleyard M.V., O'Neill M., et al. Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo. Cancer Res 2004, 64:4875-4886.
13. 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicin. J Nucl Med 2007, 48:1320-1326.
14. Shiba K., Yano T., Sato W., Mori H., Tonami N. Characterization of radioiodinated (-)-ortho-iodovesamicol binding in rat brain preparations. Life Sci 2002, 71:1591-1598.
15. Shiba K., Ogawa K., Mori H. In vitro characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino]cyclohexanol [(+)-pIV] as a sigma-1 receptor ligand. Bioorg Med Chem 2005, 13:1095-1099.
16. Ogawa K., Shiba K., Akhter N., Yoshimoto M., Washiyama K., Kinuya S., et al. Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy. Cancer Sci 2009, 100:2188-2192.
17. Tolmachev V., Lovqvist A., Einarsson L., Schultz J., Lundqvist H. Production of Br-76 by a low-energy cyclotron. Appl Radiat Isotopes 1998, 49:1537-1540.
18. 76Br]bromo-hydroxyflutamide. Nucl Med Biol 2006, 33:705-713.
19. Shiba K., Mori H., Matsuda H., Tsuji S., Tonami N., Hisada K. In vivo characterization of radioiodinated 2-(4-phenylpiperidino)cyclohexanol (vesamicol) analogs: potential radioligand for mapping presynaptic cholinergic neurons. Nucl Med Biol 1995, 22:823-828.
20. Rogers G.A., Parsons S.M., Anderson D.C., Nilsson L.M., Bahr B.A., Kornreich W.D., et al. Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol). J Med Chem 1989, 32:1217-1230.
21. Shiba K., Mori H., Matsuda H., Tsuji S., Kuji I., Sumiya H., et al. Synthesis of radioiodinated analogs of 2-(4-phenylpiperidino)cyclohexanol (vesamicol) as vesamicol-like agent. Nucl Med Biol 1995, 22:205-210.
22. Ogawa K., Kanbara H., Shiba K., Kitamura Y., Kozaka T., Kiwada T., et al. Development and evaluation of a novel radioiodinated vesamicol analog as a sigma receptor imaging agent. EJNMMI research 2012, 2:54.
23. Shiba K., Ogawa K., Ishiwata K., Yajima K., Mori H. Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor. Bioorg Med Chem 2006, 14:2620-2626.
24. Zea-Ponce Y., Mavel S., Assaad T., Kruse S.E., Parsons S.M., Emond P., et al. Synthesis and in vitro evaluation of new benzovesamicol analogues as potential imaging probes for the vesicular acetylcholine transporter. Bioorg Med Chem 2005, 13:745-753.
25. Mulholland G.K., Jung Y.W., Wieland D.M., Kilbourn M.R., Kuhl D.E. Synthesis of [F-18] fluoroethoxy-benzovesamicol, a radiotracer for cholinergic neurons. J Labelled Compd Rad 1993, 33:583-591.
26. 11C]SA4503. Nucl Med Biol 2006, 33:543-548.
27. Hall E.J., Giaccia A.J. Radiobiology for the radiologist 2012, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 7th ed.
28. Ogawa K., Washiyama K. Bone target radiotracers for palliative therapy of bone metastases. Curr Med Chem 2012, 19:3290-3300.